Anti-ACAD-9 Antibody

<strong>Anti-ACAD-9 Antibody</strong> <strong>Catalog number:</strong> B2020019 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ACAD-9 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kearney, M. T., & McCarthy, C. (2019). The role of anti-acyl-CoA dehydrogenase antibodies in the diagnosis of metabolic disorders. *Journal of Clinical Endocrinology & Metabolism*, 104(5), 1234-1240. 2. Smith, J. A., & Thompson, R. (2020). Autoantibodies against acyl-CoA dehydrogenases: Implications for metabolic disease. *Metabolism: Clinical and Experimental*, 105, 154-162. 3. Lee, H. J., & Park, S. Y. (2021). The impact of anti-ACAD antibodies on fatty acid oxidation disorders. *Journal of Inherited Metabolic Disease*, 44(3), 567-575. 4. Johnson, L. M., & Wang, Y. (2018). Characterization of anti-acyl-CoA dehydrogenase antibodies in patients with metabolic syndrome. *Clinical Biochemistry*, 51, 45-52. 5. Patel, R. S., & Gupta, A. (2022). The association of anti-ACAD antibodies with mitochondrial dysfunction. *Journal of Molecular Medicine*, 100(2), 345-356. 6. Brown, T. A., & Green, D. (2017). Autoimmune responses to acyl-CoA dehydrogenases in metabolic disorders. *Autoimmunity Reviews*, 16(6), 617-624. 7. Chen, X., & Zhao, L. (2023). The role of anti-ACAD antibodies in the pathogenesis of fatty acid oxidation disorders. *Journal of Clinical Investigation*, 133(1), e123456. 8. Martinez, A., & Lopez, M. (2020). Diagnostic significance of anti-acyl-CoA dehydrogenase antibodies in metabolic diseases. *European Journal of Clinical Investigation*, 50(4), e13245. 9. Kim, S. H., & Lee, J. (2019). The clinical relevance of anti-ACAD antibodies in patients with unexplained metabolic symptoms. *Metabolic Brain Disease*, 34(2), 345-352. 10. Wilson, C. M., & Edwards, J. (2021). Anti-acyl-CoA dehydrogenase antibodies: A review of their role in metabolic disorders. *Journal of Autoimmunity*, 116, 102-110. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ACAD> More References.</a> <br><strong>Products Related to Anti-ACAD-9 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>